| 产品详情 |
| Edit |   |
|---|
| Product Name | PT-2385 |
|---|
| Description | PT-2385 is a potent ad selective inhibitor of hypoxia inducible factor (HIF-2α) with potential antineoplastic activity. PT-2385 selectively disrupts the heterodimerization of HIF-2α with HIF-1β. Very effective in blocking cancer cell growth, proliferation, and tumor angiogenesis characteristic in clear cell renal cell carcinoma (ccRCC). MW: 383.34. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (S)-3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile; PT2385 |
|---|
| Gene, Accession, CAS # | CAS: 1672665-49-4 |
|---|
| Catalog # | B1920-5 |
|---|
| Price | |
|---|
| Order / More Info | PT-2385 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|